BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 10460602)

  • 1. A novel ELISA-based primer extension assay for the detection of the factor V Leiden mutation.
    Wilde JT; O'Sullivan JJ; Roper JL; Aerts P; Horowitz M; Navot N
    Br J Haematol; 1999 Aug; 106(2):427-30. PubMed ID: 10460602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor V Leiden genotyping using real-time fluorescent polymerase chain reaction.
    Sanders Sevall J
    Mol Cell Probes; 2000 Aug; 14(4):249-53. PubMed ID: 10970729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analytical evaluation of primer engineered multiplex polymerase chain reaction-restriction fragment length polymorphism for detection of factor V Leiden and prothrombin G20210A.
    Huber S; McMaster KJ; Voelkerding KV
    J Mol Diagn; 2000 Aug; 2(3):153-7. PubMed ID: 11229520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the factor V Leiden mutation using the READIT Assay.
    Rhodes RB; Lewis K; Shultz J; Huber S; Voelkerding KV; Leonard DG; Tsongalis GJ; Kephart DD
    Mol Diagn; 2001 Mar; 6(1):55-61. PubMed ID: 11257212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of the factor V Leiden mutation by direct allele-specific hybridization of PCR amplicons to photoimmobilized locked nucleic acids.
    Orum H; Jakobsen MH; Koch T; Vuust J; Borre MB
    Clin Chem; 1999 Nov; 45(11):1898-905. PubMed ID: 10545058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligonucleotide ligation assay for detection of the factor V mutation (Arg506-->Gln) causing protein C resistance.
    Benson JM; Phillips DJ; Holloway BP; Evatt BL; Hooper WC
    Thromb Res; 1996 Jul; 83(1):87-96. PubMed ID: 8837307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of a functional prothrombin time-based assay for identification of factor V Leiden carriers in a group of Italian patients with venous thrombosis.
    Gessoni G; Valverde S
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):603-10. PubMed ID: 17890946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allele-specific PCR amplification of factor V Leiden to identify patients at risk for thromboembolism.
    Blasczyk R; Wehling J; Ritter M; Neubauer A; Riess H
    Beitr Infusionsther Transfusionsmed; 1997; 34():236-41. PubMed ID: 9356679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-base extension and ELISA-based approach for single-nucleotide polymorphisms genotyping.
    Liu G; Cheng Y; Zhao W; Jin Z; Shan H; Xu G
    Appl Biochem Biotechnol; 2011 Mar; 163(5):573-6. PubMed ID: 20717851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical impact of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations among sickle cell disease patients of Central India.
    Nishank SS; Singh MP; Yadav R
    Eur J Haematol; 2013 Nov; 91(5):462-6. PubMed ID: 23992124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective screening for the Factor V Leiden mutation: is it advisable prior to the prescription of oral contraceptives?
    Schambeck CM; Schwender S; Haubitz I; Geisen UE; Grossmann RE; Keller F
    Thromb Haemost; 1997 Dec; 78(6):1480-3. PubMed ID: 9423798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The detection of Leiden mutation using technique of enzymatic extension of allele-specific primer with double bioluminescent detection (PED-Biolum)].
    Krasitskaia VV; Subbotina TN; Ol'khovskiĭ IA; Frank LA
    Klin Lab Diagn; 2013 Dec; (12):26, 39-41. PubMed ID: 24757862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overlapping PCR for bidirectional PCR amplification of specific alleles: a rapid one-tube method for simultaneously differentiating homozygotes and heterozygotes.
    Liu Q; Thorland EC; Heit JA; Sommer SS
    Genome Res; 1997 Apr; 7(4):389-98. PubMed ID: 9110178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biosensor for diagnosing Factor V Leiden, a single amino acid mutated abnormality of Factor V.
    Ren Y; Rezania S; Kang KA
    Adv Exp Med Biol; 2008; 614():245-52. PubMed ID: 18290335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct analysis of polymerase chain reaction products using enzyme-linked immunosorbent assay techniques.
    Landgraf A; Reckmann B; Pingoud A
    Anal Biochem; 1991 Oct; 198(1):86-91. PubMed ID: 1789435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the factor V Leiden mutation in septic peritonitis assessed in factor V Leiden transgenic mice.
    Brüggemann LW; Schoenmakers SH; Groot AP; Reitsma PH; Spek CA
    Crit Care Med; 2006 Aug; 34(8):2201-6. PubMed ID: 16775574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated protein C resistance: automated detection of the factor V Leiden mutation by mismatch hybridization.
    Klingler KR; Junold T; Wielckens K
    Clin Chem; 1999 Nov; 45(11):1925-31. PubMed ID: 10545061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor V Leiden (Arg506Gln), a confounding genetic risk factor but not mandatory for the occurrence of venous thromboembolism in homozygotes and obligate heterozygotes for cystathionine beta-synthase deficiency.
    Yap S; O'Donnell KA; O'Neill C; Mayne PD; Thornton P; Naughten E
    Thromb Haemost; 1999 Apr; 81(4):502-5. PubMed ID: 10235428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ARMS test for diagnosis of factor V Leiden mutation and allele frequencies in France.
    Bathelier C; Champenois T; Lucotte G
    Mol Cell Probes; 1998 Apr; 12(2):121-3. PubMed ID: 9633048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Separation of Factor V Leiden molecule, a mutated form of Factor V, from plasma of homozygous patient.
    Rezania S; Kang KA
    Adv Exp Med Biol; 2008; 614():101-7. PubMed ID: 18290319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.